J&J Loses Bid To Nix Levaquin Award In 8th Circ.

Law360, New York (January 7, 2014, 4:41 PM EST) -- The Eighth Circuit said Tuesday that Johnson & Johnson’s pharmaceutical unit must pay $630,000 to a patient who claimed the company deliberately failed to properly warn consumers of the risks linked to its antibiotic Levaquin, saying there was no misconduct that could justify overturning the award.

Ortho-McNeil-Janssen Pharmaceuticals Inc. had argued to the appeals court that plaintiff John Schedin’s expert biostatistician admitted after trial that he had not — as Schedin represented — provided all the information OMJP requested during discovery regarding his relative-risk calculations and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

John Schedin v. Ortho-McNeil-Janssen


Case Number

12-3200

Court

Appellate - 8th Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

September 19, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.